Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-31

Clinical Trial Update: Exploring the Anti-ageing Effects of Metformin in COPD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the potential anti-aging effects of metformin in chronic obstructive pulmonary disease, with the study not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Fundación Instituto de Investigación Sanitaria de Navarra | Conditions: COPD | Phase 3 | Status: NOT_YET_RECRUITING